Clinical trial
A Multi-centre Randomised Controlled Trial of Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease (PSG4NIVinMND; 3, Three Letter Acronyms [3TLA])
NCT05136222 is registered in ClinicalTrials.gov with University of Melbourne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-centre Randomised Controlled Trial of Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease (PSG4NIVinMND; 3, Three Letter Acronyms [3TLA])
- Lead sponsor
- University of Melbourne
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 15, 2021
- Completion date
- February 28, 2028
- Enrollment
- 244 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
motor neuron disease / amyotrophic lateral sclerosis